The question, I believe is, wouldn't over 95% of these people be dead in 5 years in spite of being stabilized when the vaccine doses were begun. If not, what percentage would be anticipated to survive 5 years. If that number should be 10% surviving at 5 years we'll still have more than doubled the anticipated outcome.
I certainly see where you're coming from, if we're taking the top 25% of the patients, I believe it's still clear that of that group not that many would survive regardless, though the roughly 4+% who do survive 5 years would probably come out of this group. If we even make a case for 15% of them surviving 5 years our numbers could be double or better than that if looking only at patients who received the vaccine up front, thought this is data we've never seen before, so I'm guessing. I do believe that benefits will be seen from many crossed over patients as well.
Let's get the data, then we'll know.
Gary
Market Data 
Markets 
AI
